The Emerging Role of NANOG as an Early Cancer Risk Biomarker in Patients with Oral Potentially Malignant Disorders
NANOG, a key regulator of pluripotency and self-renewal in embryonic and adult stem cells, is frequently overexpressed in multiple cancers, including oral squamous cell carcinoma (OSCC). It has been frequently associated with poor outcomes in epithelial cancers, and recently implicated in laryngeal...
Main Authors: | Juan C. de Vicente, Tania Rodríguez-Santamarta, Juan P. Rodrigo, Eva Allonca, Aitana Vallina, Anusha Singhania, Paula Donate-Pérez del Molino, Juana M. García-Pedrero |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-09-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/8/9/1376 |
Similar Items
-
SOX2 Expression Is an Independent Predictor of Oral Cancer Progression
by: Juan C. de Vicente, et al.
Published: (2019-10-01) -
Midkine and NANOG Have Similar Immunohistochemical Expression Patterns and Contribute Equally to an Adverse Prognosis of Oral Squamous Cell Carcinoma
by: Hyun-Min Kim, et al.
Published: (2017-11-01) -
Histomorphometric Analysis of Angiogenesis using CD31 Immunomarker and Mast Cell Density in Oral Premalignant and Malignant Lesions: A Pilot Study
by: M Jyothsna, et al.
Published: (2017-01-01) -
Importance of Ki-67 Labeling in Oral Leukoplakia with Features of Dysplasia and Carcinomatous Transformation: An Observational Study over 4 Years
by: Krishnendu Mondal, et al.
Published: (2020-06-01) -
Expression of E-cadherin in oral epithelial dysplasia and oral squamous cell carcinoma: An in vivo study
by: Avadhoot Avadhani, et al.
Published: (2011-12-01)